Therapeutic Effects of Jing Si Herbal Tea for COPD
Recruiting
Early Phase 1
Interventional Study
Airway Disease
At a Glance
- Age
- 20 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chronic obstructive pulmonary disease (COPD), a leading cause of global mortality, significantly impairs health-related quality of life (HRQL). COPD is characterized by airway inflammation and lung tissue damage. Jing Si herbal tea (JSHT) is known to have anti-inflammatory effects but has not been explored for treating COPD. This study investigated the potential of JSHT as an adjuvant therapy for …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* COPD patients willing to enter this study
Exclusion Criteria:
* not COPD patients, no willing to enter this study
Contacts